Aurefluidics Technology Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$13.7M
- Investors
-
7
Aurefluidics Technology General Information
Description
Developer of microfluidic devices designed for biomedical applications. The company's platform integrates CMOS-MEMS inkjet printing chips, microfluidic design, cell printing, temperature control, and system integration, enabling researchers and healthcare professionals to advance drug development, diagnostics, and treatment through high-performance and reliable microfluidic solutions.
Contact Information
Website
www.aurefluidics.comCorporate Office
- Room 401, 4th Floor, North Building, Building 3
- No. 333 Huangqing Road, Jiading District
- Shanghai, 200180
- China
Corporate Office
- Room 401, 4th Floor, North Building, Building 3
- No. 333 Huangqing Road, Jiading District
- Shanghai, 200180
- China
Aurefluidics Technology Timeline
Aurefluidics Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B1) | 22-Jan-2025 | $13.7M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 13-Nov-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Sep-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Apr-2019 | Completed | Generating Revenue |
Aurefluidics Technology Patents
Aurefluidics Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023201942-A1 | Single-cell sorting microfluidic chip and single-cell sorting method | Inactive | 22-Apr-2022 | ||
| JP-2025511210-A | Microfluidic chip and method for culturing single cells and sorting and extracting cell populations - patents.com | Active | 31-Mar-2022 | ||
| JP-7909615-B2 | Microfluidic chip and method for culturing single cells and sorting and extracting cell populations. | Active | 31-Mar-2022 | ||
| EP-4506443-A1 | Microfluidic chip and methods for culturing single cell and screening and exporting cell population | Pending | 31-Mar-2022 | ||
| EP-4506443-A4 | Microfluidic chip and methods for culturing single cell and screening and exporting cell population | Pending | 31-Mar-2022 | G01N33/5047 |
Aurefluidics Technology Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xingcheng Capital | Growth/Expansion | Minority | ||
| Hopesun Capital | PE/Buyout | Minority | ||
| MGI Tech | Corporation | Minority | ||
| Origins Capital | Venture Capital | Minority | ||
| Xiamen Hi-Tech Innovation Center | Venture Capital | Minority |
Aurefluidics Technology FAQs
-
When was Aurefluidics Technology founded?
Aurefluidics Technology was founded in 2018.
-
Where is Aurefluidics Technology headquartered?
Aurefluidics Technology is headquartered in Shanghai, China.
-
What industry is Aurefluidics Technology in?
Aurefluidics Technology’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Aurefluidics Technology a private or public company?
Aurefluidics Technology is a Private company.
-
What is Aurefluidics Technology’s current revenue?
The current revenue for Aurefluidics Technology is .
-
How much funding has Aurefluidics Technology raised over time?
Aurefluidics Technology has raised $13.7M.
-
Who are Aurefluidics Technology’s investors?
Xingcheng Capital, Hopesun Capital, MGI Tech, Origins Capital, and Xiamen Hi-Tech Innovation Center are 5 of 7 investors who have invested in Aurefluidics Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process